Alexandra Drane

President and Co-founder
Eliza Corporation

Alexandra Drane has devoted her career to inspiring people to lead healthier, happier and more engaged lives through the use of innovative technology. Her entrepreneurial spirit and passion for technology and design have led to the launch of four successful healthcare ventures over the past 15 years. Alexandra has proven herself an innovator, whose ideas on using technology to engage people in their health – and her belief in adding a touch of joy to the often staid world of healthcare communications – have been adopted by the nation’s top healthcare organizations. Alexandra is currently president and co-founder of Eliza Corporation, a leading provider of integrated healthcare communication strategies and one of Entrepreneur magazine’s “100 Brilliant Companies” (2009). Eliza draws on its database of more than 400 million interactions with individuals about their health to better understand what makes people “tick” and create programs with measurable and sustained impact – from increasing the number of patients who get their recommended diabetes screenings by 76%, to quadrupling participation in an online smoking cessation program, and more. The company’s intelligent, tailored interactions make health and healthcare information more accessible, more actionable and more engaging. Alexandra is also a co-founder of Engage with Grace, a not-for-profit movement launched in October 2008 aimed at helping people understand, communicate and have honored their end-of-life wishes. She received the Boston Business Journal’s “Champions of Healthcare” award for her efforts in this area, and in 2009 Engage With Grace was one of the top ten phrases added to the healthcare lexicon.  Based on her experience engaging people in conversation about health topics, in 2010 she also co-founded a non-profit, web-based movement called SeduceHealth that aims to reframe how the healthcare industry communicates with the people it serves by adding greater passion, joy, and inspiration.

Comments are closed.